Last updated: June 7, 2021
As the Covid-19 pandemic remains a serious risk here and across the globe, a modified Covid-19 travel policy will remain in effect. This is in addition to MIT’s existing International Travel Risk Policy.
While MIT policy may permit travel to some countries by some community members, we anticipate that the global travel landscape will remain volatile for some time to come. In particular, international travel will be extremely complicated at best and essentially unfeasible in many instances.
MIT community members who travel outside of Massachusetts for more than 24 hours and who reside or work on campus should consult the travel reentry policy for more details on testing and quarantine requirements. Note that even if you have been vaccinated, you must continue to test and meet all other requirements.
MIT travelers should understand the Covid testing, quarantine, and/or vaccination requirements imposed by their transportation provider and/or destination. We urge all travelers to understand the risks and local conditions, carefully plan for contingencies, and exercise great caution while in transit and once they arrive at their destination.
Effective June 1, 2021, Covid-19 vaccination is required for MIT-related domestic and international travel. This requirement applies to undergraduate and graduate students, staff, faculty, and postdocs. The requirement does not apply to local travel (within the six New England states) or to MIT travelers with an approved medical or religious exemption from the vaccination requirement.
Guidance at a glance
Please note that all MIT-related travel must be registered in Covid Travel. Travelers should be aware that, if the CDC or DOS risk level for your destination changes prior to departure, you may be required to request an exception or you may need to postpone or cancel your trip. Travelers are urged to plan accordingly. Planning resources for travelers are available on the ICC website.
Step one: CDC Covid risk assessment
Please refer to the CDC website for updated country Covid-19 risk ratings.
|Travel to countries with CDC Covid risk level 1 or 2: Low or moderate risk||Undergraduate students: Not allowed except with approved programs or via exception process for essential travel|
Graduate students/staff/faculty/postdocs: Allowed
|Travel to countries with CDC Covid risk level 3 or 4: High or very high risk||Undergraduate students: Not allowed; no exceptions|
Graduate students/staff/faculty/postdocs: Not allowed except via exception process for essential travel
Step two: Department of State risk assessment
If travel is allowable by the policy above, undergraduate and graduate students should then check the Department of State (DOS) website for the overall risk rating of their destination. (This rating takes into account a wider variety of factors including crime, terrorism, civil unrest, and natural disasters, along with other non-Covid health risks).
If the country is a DOS level 3 or 4 (high or very high risk) for reasons other than Covid-19, undergraduate and graduate students must apply for a high-risk travel waiver. Staff and faculty members may travel to DOS level 3 and 4 countries with no exceptions required. If you are uncertain which application form to use, please contact the High Risk Travel Committee for assistance.
Local and domestic MIT-related travel
|Local travel (within the 6 New England states of CT, MA, ME, NH, RI, VT): Allowed for all (undergraduate students, graduate students, staff, faculty, and postdocs). Follow Commonwealth guidelines or guidelines of your originating location.|
|Domestic travel by undergraduate students: Not allowed except with approved programs or exception process for essential individual travel.|
|Domestic travel by graduate students/staff/faculty/postdocs: Allowed|
Use personal judgment and register travel (encouraged).
Exceptions process for essential travel
Exceptions may be made in the case of essential travel for all travelers except for undergraduates (as noted above).
Essential travel is defined as travel that:
- Advances critical research in the national or global interest.
- Preserves the continuity of research that cannot be repeated, replaced, performed remotely or by proxy, or that is necessary to preserve the safety/well-being of research subjects.
- Supports a critical MIT research, educational, or administrative/operational function that cannot be deferred or accomplished remotely.
- For students, maintains progress toward academic degree and that cannot be postponed, replaced, or accomplished remotely or by proxy.
Individuals with essential travel needs must apply for an exception. Requests with the required endorsements will be reviewed by the MIT High-Risk Travel Committee and then forwarded to the appropriate individual or group for a final decision.
|Undergraduate students||Graduate students||Administrative and research staff, faculty, and postdocs|
|Exception required for:||Essential domestic travel|
Essential international travel to countries with CDC Covid risk level 1 and 2 OR Department of State risk level 3 or 4
Travel with MIT-approved programs does not require an individual exception
|Essential international travel to countries with CDC Covid risk level 3 or 4 OR Department of State risk level 3 or 4||Essential international travel to countries with CDC Covid risk level 3 or 4|
|Required endorsement||DLC head||PI or advisor and DLC head||Direct supervisor (administrative staff); DLC head or PI (faculty, research staff, postdocs)|
|Risk review and recommendation||High-Risk Travel Committee||High-Risk Travel Committee||High-Risk Travel Committee|
|Final decision||Vice chancellor||Vice chancellor||Relevant Academic Council member (administrative staff); Deans’ Council and vice president for research (faculty, research staff, and postdocs)|